Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WEE1 | P30291 | 5/20 | 0.52 |
| ▸ | MET | P08581 | 3/20 | 0.51 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.51 |
| ▸ | BTK | Q06187 | 2/20 | 0.49 |
| ▸ | AXL | P30530 | 6/20 | 0.48 |
| ▸ | TYRO3 | Q06418 | 6/20 | 0.48 |
| ▸ | MERTK | Q12866 | 6/20 | 0.48 |
| ▸ | MAP4K1 | Q92918 | 3/20 | 0.46 |
| ▸ | MAP4K3 | Q8IVH8 | 2/20 | 0.46 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.46 |
| ▸ | IGF1R | P08069 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30642937 | 1.00 | WEE1 (0.52) | WEE1METALKBTKAXL | |
| SCHEMBL26624018 | 0.93 | MET (0.53) | WEE1METALKBTKAXL | |
| SCHEMBL31448272 | 0.87 | MAP4K1 (0.56) | MAP4K1MAP4K3IRAK4 | |
| SCHEMBL26624021 | 0.87 | MAP4K1 (0.56) | MAP4K1MAP4K3IRAK4 | |
| SCHEMBL31442213 | 0.83 | WEE1 (0.48) | WEE1METALKBTKAXL | |
| SCHEMBL30642959 | 0.82 | BTK (0.50) | WEE1METALKBTKAXL | |
| SCHEMBL31442105 | 0.82 | WEE1 (0.52) | WEE1METALKBTKAXL | |
| SCHEMBL31442100 | 0.81 | AXL (0.53) | WEE1METALKBTKAXL | |
| SCHEMBL31442144 | 0.80 | MET (0.53) | WEE1METALKBTKAXL | |
| SCHEMBL30642956 | 0.79 | TYRO3 (0.55) | ALKBTKAXLTYRO3MERTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015340-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-15 | — | — | US | claimed |
| EP-4520757-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | Korea Research Institute of Chemical Technology (KR) | 2025-03-12 | — | — | EP | claimed |
| WO-2023214772-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 한국화학연구원 | 2023-11-09 | — | — | WO | claimed |
| US-20260015340-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-15 | — | — | US | disclosed |
| EP-4520757-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | Korea Research Institute of Chemical Technology (KR) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023214772-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 한국화학연구원 | 2023-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015340-A1 | COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | MINK1, HK1, PDK3 | WEE1 50/4885MET 366/4885ALK 1049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.